Amphibian Mortality Due To UV Radiation

February 17, 1998

New Haven, Conn. D Many frog and other amphibian species throughout the world appear to be experiencing declining populations, with several species already extinct and others showing alarming rates of deformities. No single cause has been identified. Some scientists believe habitat disturbances are to blame, although declines have occurred in relatively undisturbed areas.

Now, field experiments in the Oregon Cascade Mountains have confirmed what many scientists had suspected -- ambient levels of ultraviolet-B (UV-B) radiation from the sun can cause high rates of mortality and deformity in some species of frogs and other amphibians. The earth is shielded from UV radiation by the ozone layer, which is believed to be thinning because of the increased use of chlorofluorocarbons as refrigerants, solvents and cleaning agents.

"There has been a great deal of recent attention to the suspected increase in amphibian deformities. However, most reports have been anecdotal, and no experiment in the field under natural conditions had been performed previously," said Joseph M. Kiesecker of Yale University, who presented his findings Feb. 17 at the annual meeting of the American Association for the Advancement of Science in Philadelphia.

Kiesecker, along with Andrew R. Blaustein of Oregon State University, compared the embryos of long-toed salamanders shielded from UV-B radiation by mylar filters to unshielded embryos. They found that 95 percent of the shielded embryos hatched, compared to only 14.5 percent of the unshielded embryos. Even more striking, only 0.5 percent of the surviving shielded salamanders had deformities while 91.9 percent of the unshielded salamanders had deformities. Malformed tails, blisters and edema were the most frequent deformities.

"The recent thinning of the protective ozone layer in the upper atmosphere has been linked to increased risks of skin cancer and cataracts in humans as well as to the destruction of fragile plant life. Deformed and dying frogs may be linked to thinning ozone as well," said Kiesecker, who is studying other possible factors, such as water level and quality, which also can affect the amount of UV-B radiation reaching amphibians.

UV-B radiation also may impair disease defense mechanisms, making amphibians more susceptible to pathogens and parasites that may hamper normal development and increase mortality, Kiesecker said. For example, he found increased mortality associated with a pathogenic fungus (Saprolegnia ferax) infecting some embryos exposed to UV-B, while embryos under mylar filters were not infected. The UV-B may work synergistically with the fungus, said Kiesecker, who reports seeing an outbreak of fungal pathogens in a number of amphibian species in the last 10 years.

Amphibians are ideal species for the study of UV-B exposure, he noted. Many lay their eggs in open, shallow water where exposure to UV-B is high. Typically, a population of 200 breeding pairs of toads, for example, will produce as many as 1 million embryos. Furthermore, amphibian species have varying amounts of an enzyme called photolyase, which is the principal enzyme for repairing UV damage to DNA. Photolyase attacks a major UV photoproduct in DNA -- cyclobutane pyrimidine dimers -- which can cause mutations and cell death if left unchecked.

Kiesecker, a zoologist and postdoctoral fellow, reported that frog and toad species with the greatest photolyase activity had the lowest mortality rates in developing embryos. For example, he and his colleagues noted an increase in embryo mortality of 15 to 20 percent in the Western toad and the Cascade frog -- two species with low levels of photolyase -- while the Pacific tree frog, which has a high photolyase level, is thriving. All three species live in the same habitat in the Cascade Mountains.

The field studies, which were completed in May and June 1997, also are reported in part in the December issue of the Proceedings of the National Academy of Sciences. Funding was from the National Science Foundation and the Donnelley Fellowship sponsored by the Yale Institute for Biospheric Studies.

Yale University

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to